The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1379
ISSUE1379
December 12, 2011
Fentanyl Nasal Spray (Lazanda) for Pain
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Fentanyl Nasal Spray (Lazanda) for Pain
December 12, 2011 (Issue: 1379)
The FDA has approved a nasal spray formulation of
fentanyl (Lazanda – Archimedes) for management of
breakthrough pain in adult cancer patients who are
already receiving and are tolerant to opioid therapy.
Fentanyl is already available in the US...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.